Immunoprecise Antibodies Ltd - ESG Rating & Company Profile powered by AI
This page is a free Sustainability report for Immunoprecise Antibodies Ltd. Complete Sustainability analysis of Immunoprecise Antibodies Ltd are accessed by signing up for free. If you work at Immunoprecise Antibodies Ltd and you would like to use your Sustainability rating, please contact us.
Immunoprecise Antibodies Ltd in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 4.6; made up of an environmental score of 4.0, social score of 4.0 and governance score of 5.7.
4.6
Medium ImpactEnvironmental
Social
Governance
Peer Group Comparison
| Rank | Company | SDG Transparency Score ⓘ | Performance |
|---|---|---|---|
| 1 | Novartis AG | 9.2 | High |
| 2 | Daiichi Sankyo Co Ltd | 8.9 | High |
| 1156 | Vectus Biosystems Ltd | 4.7 | High |
| 1156 | Zynerba Pharmaceuticals Inc | 4.7 | High |
| 1199 | Immunoprecise Antibodies Ltd | 4.6 | High |
| 1199 | Allergan Inc | 4.6 | High |
| 1199 | AroCell AB (publ) | 4.6 | High |
| ... | ... | ... | |
| 2749 | Xynomic Pharmaceuticals Holdings Inc | 0.0 | Low |
| 2749 | Zyden Gentec Ltd | 0.0 | Low |
| ... | ... | ... |
Frequently Asked Questions
Does Immunoprecise Antibodies Ltd have an accelerator or VC vehicle to help deliver innovation?
Sign up for free to unlockDoes Immunoprecise Antibodies Ltd disclose current and historical energy intensity?
Sign up for free to unlockDoes Immunoprecise Antibodies Ltd report the average age of the workforce?
Sign up for free to unlockDoes Immunoprecise Antibodies Ltd reference operational or capital allocation in relation to climate change?
Sign up for free to unlockDoes Immunoprecise Antibodies Ltd disclose its ethnicity pay gap?
Sign up for free to unlockDoes Immunoprecise Antibodies Ltd disclose cybersecurity risks?
Sign up for free to unlockDoes Immunoprecise Antibodies Ltd offer flexible work?
Sign up for free to unlockDoes Immunoprecise Antibodies Ltd have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Sign up for free to unlockDoes Immunoprecise Antibodies Ltd disclose the number of employees in R&D functions?
Sign up for free to unlockDoes Immunoprecise Antibodies Ltd conduct supply chain audits?
Sign up for free to unlockDoes Immunoprecise Antibodies Ltd disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Sign up for free to unlockIs there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Sign up for free to unlockDoes Immunoprecise Antibodies Ltd conduct 360 degree staff reviews?
Sign up for free to unlockDoes Immunoprecise Antibodies Ltd disclose the individual responsible for D&I?
Sign up for free to unlockDoes Immunoprecise Antibodies Ltd disclose current and historical air emissions?
Sign up for free to unlockIs there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Sign up for free to unlockIs executive remuneration linked to climate performance?
Sign up for free to unlockDoes the Board describe its role in the oversight of climate-related risks and opportunities?
Sign up for free to unlockDoes Immunoprecise Antibodies Ltd disclose current and / or historical scope 2 emissions?
Sign up for free to unlockDoes Immunoprecise Antibodies Ltd disclose water use targets?
Sign up for free to unlockDoes Immunoprecise Antibodies Ltd have careers partnerships with academic institutions?
Sign up for free to unlockDid Immunoprecise Antibodies Ltd have a product recall in the last two years?
Sign up for free to unlockDoes Immunoprecise Antibodies Ltd disclose incidents of discrimination?
Sign up for free to unlockDoes Immunoprecise Antibodies Ltd allow for Work Councils/Collective Agreements to be formed?
Sign up for free to unlockHas Immunoprecise Antibodies Ltd issued a profit warning in the past 24 months?
Sign up for free to unlockDoes Immunoprecise Antibodies Ltd disclose parental leave metrics?
Sign up for free to unlockDoes Immunoprecise Antibodies Ltd disclose climate scenario or pathway analysis?
Sign up for free to unlockDoes Immunoprecise Antibodies Ltd disclose current and / or historical scope 1 emissions?
Sign up for free to unlockAre Operating Expesnses linked to emissions reduction?
Sign up for free to unlockDoes Immunoprecise Antibodies Ltd disclose the pay ratio of women to men?
Sign up for free to unlockDoes Immunoprecise Antibodies Ltd support suppliers with sustainability related research and development?
Sign up for free to unlockDoes Immunoprecise Antibodies Ltd disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Sign up for free to unlockDoes Immunoprecise Antibodies Ltd reflect climate-related risks in its financial statements?
Sign up for free to unlockIs there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Sign up for free to unlockIs Immunoprecise Antibodies Ltd involved in embryonic stem cell research?
Sign up for free to unlockDoes Immunoprecise Antibodies Ltd disclose GHG and Air Emissions intensity?
Sign up for free to unlockDoes Immunoprecise Antibodies Ltd disclose its waste policy?
Sign up for free to unlockDoes Immunoprecise Antibodies Ltd report according to TCFD requirements?
Sign up for free to unlockDoes Immunoprecise Antibodies Ltd disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Sign up for free to unlockDoes Immunoprecise Antibodies Ltd disclose energy use targets?
Sign up for free to unlockDoes Immunoprecise Antibodies Ltd disclose its Renewable Energy targets?
Subscription requiredAre emissions metrics verified by STBi?
Subscription requiredDoes Immunoprecise Antibodies Ltd have a policy relating to cyber security?
Sign up for free to unlockHave a different question?
Potential Risks for Immunoprecise Antibodies Ltd
These potential risks are based on the size, segment and geographies of the company.
ImmunoPrecise Antibodies Ltd., together with its subsidiaries, engages in antibody production and related services in the United States, Canada, Europe, and internationally. The company offers a range of antibodies, enzymes, enzyme activity assays, arthritis animal products, proteins, deiminated proteins, organoid growth factors, and hybridoma products for research purposes. Its services include custom antigen modeling, design, and manufacturing; B cell sorting, screening, and sequencing; custom, immune, and naive phage display production and screening; transgenic animals and multi-species antibody discovery; bi-specific, tri-specific, VHH, and VNAR (shark) antibody manufacturing; DNA cloning, protein and antibody downstream processing; antibody characterization on label-free biosensors and antibody engineering; transient and stable cell line generation; antibody optimization and humanization; hybridoma production with multiplexed, high-throughput screening, and clone-picking; and cryopreservation. The company has research collaboration agreements with Pierre Fabre S.A for antibody discovery; and Elektrofi, Inc. to explore a high-concentration formulation of COVID-19 antibody cocktail, PolyTope TATX-03. ImmunoPrecise Antibodies Ltd. was incorporated in 1983 and is based in Victoria, Canada.